Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
LHFP
REST API REST API
Homo sapiens
LHFP is differentially expressed in 242 experiments: 122 organism parts: liver, bone marrow, ... (120 more);, 224 disease states: normal, acute myeloid leukemia, ... (222 more);, 92 cell types 502 cell lines 21 compound treatments and 64 other conditions.
Synonyms MGC22429
Orthologs Q0P5D5_BOVIN (Bos taurus)   Lhfp (Rattus norvegicus)   lhfp (Danio rerio)   Lhfp (Mus musculus)   LHFP (Gallus gallus)   lhfp (Xenopus laevis)   LHFP (Canis familiaris)   (Compare orthologs)
Gene Ontology Term DNA binding, membrane, integral to membrane
InterPro Term Lipome_HGMIC_fus_partner-like
UniProt Accession Q9Y693
Search EB-eye ENSG00000183722
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-AFMX-5, E-GEOD-6573, E-MEXP-1251, ... (24 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-3860, E-GEOD-5258, E-GEOD-4525, E-GEOD-19639, ... (43 experiments)

Factor Value U/D Experiments
BT474
3
E-MEXP-440, E-MTAB-37, E-MTAB-62
MCF-7
3
E-GEOD-20081, E-GEOD-3529, E-GEOD-19639
MDA-MB-231
3
E-TABM-420, E-MTAB-62, E-GEOD-5823
H1
2
E-MTAB-62, E-GEOD-1309
A549
2
E-GEOD-3202, E-GEOD-6013
CCRFCEM
2
E-MTAB-37, E-GEOD-24147
496 more value(s).


Cell type

studied in E-GEOD-21668, E-GEOD-3920, E-MEXP-750, E-GEOD-20677, E-GEOD-13987, ... (47 experiments)

Factor Value U/D Experiments
2
E-TABM-145, E-TABM-130
embryonic stem cell
2
E-GEOD-2248, E-MEXP-930
endothelial cell
2
E-GEOD-19240, E-GEOD-3920
human embryonic stem cell
2
E-GEOD-20033, E-GEOD-18265
stromal cell
2
3
E-MEXP-2034, E-GEOD-1460, E-MEXP-1327, E-GEOD-3998, E-GEOD-10797 ... (5 experiments)
adipocyte
1
2
E-AFMX-5, E-MTAB-25, E-TABM-145
86 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-1577, E-MEXP-1121, E-TABM-15, E-GEOD-16363, ... (57 experiments)

Factor Value U/D Experiments
glioblastoma
3
E-GEOD-4290, E-MTAB-37, E-MTAB-62
lymphoma
2
E-MTAB-62, E-MTAB-37
T-cell acute lymphoblastic leukemia
2
E-MTAB-37, E-GEOD-1577
breast cancer
2
E-MTAB-62, E-GEOD-22544
cervical carcinoma
2
E-MTAB-62, E-MEXP-1331
colon carcinoma
2
E-MTAB-62, E-MTAB-37
218 more value(s).


Compound treatment

studied in E-GEOD-15205, E-GEOD-5741, E-GEOD-15811, E-GEOD-5099, E-MEXP-1958, ... (13 experiments)

Factor Value U/D Experiments
ZMYM2/FGFR1
1
E-GEOD-15811
5-aza-2'-deoxycytidine + trichostatin A
1
1
E-MEXP-1269
vanadium pentoxide
1
E-GEOD-5339
TNF
1
E-GEOD-15205
M-CSF
1
E-GEOD-5099
Cxcl12
1
E-GEOD-7307
15 more value(s).


Age at diagnosis

studied in E-GEOD-3494, E-GEOD-4922

Factor Value U/D Experiments
86
1
E-GEOD-3494
86 years
1
E-GEOD-4922


Agent
studied in E-GEOD-19519

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

cd34
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Chromosomal aberration
studied in E-TABM-125, E-GEOD-1729

Clinical history
studied in E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-TABM-125, E-GEOD-21374, ... (8 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-MEXP-1251, E-GEOD-19246, ... (11 experiments)

Clinical treatment
studied in E-GEOD-5377, E-GEOD-2171, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-5999, E-GEOD-20033, E-MEXP-2359, E-GEOD-4667, E-MEXP-2283, ... (6 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-21138, E-GEOD-19665

double amplification
studied in E-GEOD-22601

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518

Estrogen receptor status
studied in E-GEOD-6532

Ethnicity
studied in E-GEOD-16363

Genetic modification
studied in E-MEXP-1482, E-GEOD-7578, E-GEOD-20847, E-MEXP-2340, E-MEXP-563 ... (5 experiments)

Genotype
studied in E-TABM-763, E-GEOD-3494, E-GEOD-17476, E-TABM-321, E-TABM-868, ... (6 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-MEXP-1220, E-TABM-127, E-GEOD-19018, E-GEOD-9764, ... (11 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276, E-GEOD-20194, E-GEOD-16716 ... (5 experiments)

Individual
studied in E-MTAB-197, E-TABM-325, E-MEXP-1290, E-TABM-666, E-MEXP-1648, ... (20 experiments)

Infection
studied in E-GEOD-12108

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Ki67 ihc
studied in E-GEOD-21653

Material type
studied in E-GEOD-9171

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism status
studied in E-GEOD-19188

Phenotype
studied in E-GEOD-21750, E-GEOD-1657, E-GEOD-17636, E-GEOD-2487

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-19246

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-18791, E-GEOD-17204

RNAi
studied in E-GEOD-1676, E-MEXP-101, E-GEOD-3697, E-MEXP-1857

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-19069, E-GEOD-8052, E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11886

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Test result
studied in E-TABM-276

Tissue
studied in E-GEOD-30573

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-16837, E-GEOD-19246

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments 00 005
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-3494, E-GEOD-1561, E-GEOD-4922

Processing time: 0.492 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM